Name
RF5-01: Cancer-specific risks associated with germline PALB2 pathogenic variants from a large clinical genetic testing cohort - Commentary by: William Gradishar, MD, FASCO, FACP
Date & Time
Thursday, December 4, 2025
Speakers
Virtual Session Link
Total Minutes
04:59
OnDemand Video URL